Intellia Therapeutics, Inc. (NTLA) › Cost of RevenueIntellia Therapeutics, Inc. (NTLA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearCost of RevenueChange YoY2021$0—2020$0—2019$0—2018$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share